´Ý±â
TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Ű¿öµå°Ë»ö
°Ë»ö
´Ý±â
  • °í°´Áö¿ø 
  • ¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢02-2081-2510
  • Email     ¦¢support@takara.co.kr
  • ¾÷¹«½Ã°£¾È³»
  • [ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
  • Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.
Home > ÀüÁ¦Ç°º¸±â > Stem Cell > hiPSC/hESC > Human iPS Cell Line Kits

Human iPS Cell Line Kits

-

Á¦Á¶»ç Á¦Ç°ÄÚµå Á¦Ç°¸í ¿ë·® °¡°Ý
(ºÎ°¡¼¼º°µµ)
ºñ°í »ç¿ëÀڸŴº¾ó
Cellartis
Y00275
Cellartis human iPS cell line 7 (ChiPSC7) Kit
°ü·ÃÇмú ±¸¸ÅÇϱâ LMOÁ¦Ç°  ¶óÀ̼±½º 
1 Kit
(Package)
°¡°Ý¹®ÀÇ   x32568
Cellartis
Y00285
Cellartis human iPS cell line 12 (ChiPSC12) Kit
°ü·ÃÇмú ±¸¸ÅÇϱâ LMOÁ¦Ç°  ¶óÀ̼±½º 
1 Kit
(Package)
°¡°Ý¹®ÀÇ   x32568
Cellartis
Y00305
Cellartis human iPS cell line 18 (ChiPSC18) Kit
°ü·ÃÇмú ±¸¸ÅÇϱâ LMOÁ¦Ç°  ¶óÀ̼±½º 
1 Kit
(Package)
°¡°Ý¹®ÀÇ   x32568
Cellartis
Y00325
Cellartis human iPS cell line 22 (ChiPSC22) Kit
°ü·ÃÇмú ±¸¸ÅÇϱâ LMOÁ¦Ç°  ¶óÀ̼±½º 
1 Kit
(Package)
°¡°Ý¹®ÀÇ   x32568

±¸¸Å½Ã ¾Æ·¡ÀÇ ¡°Purchase Agreement¡±¸¦ ÀÛ¼ºÇÏ¿©, ±¸¸Åó¿¡ Á¦°øÇØÁֽñ⠹ٶø´Ï´Ù.
"Purchase Agreement" ´Ù¿î¹Þ±â
¶ÇÇÑ, º» Á¦Ç°Àº ±â¾÷ü ±¸¸Å½Ã ¶óÀ̼±½º °è¾àÀÌ ÇÊ¿äÇÕ´Ï´Ù. (³»ºÎ ¿¬±¸¿ë Æ÷ÇÔ)

  • Cell lines were created by reprogramming human skin fibroblasts using defective polycistronic retrovirus technology to deliver Oct-4, SOX2, KLF4, and c-Myc
  • Cell lines are extensively analyzed for purity and stem-cell characteristics, including recovery after thawing, absence of mycoplasma and bacteria, expression of stem cell-specific markers (Oct-4, NANOG, SSEA-3, SSEA-4, TRA-1-60, TRA-1-81), absence of differentiation markers (Beta-3 tubulin, FOXA2, ASMA), and expected karyotype
  • Optimized for culture with the Cellartis DEF-CS Culture System
  • Suitable for all major applications; cells can form derivatives of all three germ layers when differentiated
  • Kits include the Cellartis DEF-CS 100 Culture System

¡Ø º» Á¦Ç°ÀÇ ¼¼Æ÷ÁÖ´Â Àΰ£ÀÇ ÇǺΠ¼¶À¯¾Æ¼¼Æ÷ (human skin fibroblasts)¿¡¼­ À¯·¡ÇÏ¿´½À´Ï´Ù. ±âÁõÀÚÀÇ Á¤º¸¿Í ÇÙÇü (karyotype) µîÀÇ ÀÚ¼¼ÇÑ Á¤º¸´Â Á¦Ç° CoA¸¦ Âü°íÇϽñ⠹ٶø´Ï´Ù.
Á¦Ç°¼³¸í
Cellartis Human iPS Cell Line Kit´Â »ê¾÷°èÀÇ Ç¥ÁØ¿¡ µû¶ó º¸°ü ¹× ºÐ¼®ÀÌ ¿Ï·áµÈ Àΰ£ À¯µµ¸¸´ÉÁٱ⼼Æ÷ (human induced pluripotent stem cell: hiPS)¿Í Cellartis DEF-CS Culture SystemÀÌ ÇÔ²² Á¦°øµÈ´Ù.

iPS¼¼Æ÷ÁÖ´Â Cellartis DEF-CS Culture System¿¡ ÃÖÀûÈ­ µÇ¾î ÀÖ¾î feeder-free, defined environment Á¶°Ç¿¡¼­ ½±°Ô ¹è¾çÇÒ ¼ö ÀÖ´Ù. Cellartis DEF-CS Culture SystemÀ¸·Î iPS ¼¼Æ÷ÁÖ ¹è¾ç ½Ã background differentiationÀÌ °ÅÀÇ ¾ø´Â ¹ÌºÐÈ­ »óŸ¦ À¯ÁöÇÒ ¼ö ÀÖ¾î, º°µµÀÇ selection °úÁ¤À» ÇÊ¿ä·Î ÇÏÁö ¾Ê´Â´Ù.

ÀÌ Á¦Ç°Àº ¾ÈÁ¤ÀûÀÎ ¼ºÀå·üÀ» º¸ÀÌ´Â iPS¼¼Æ÷ÁÖ¿Í Å¹¿ùÇÑ ÀçÇö¼ºÀ» °¡Áø Cellartis DEF-CS Culture System·Î ±¸¼ºµÇ¾î ¼¼Æ÷ÀÇ ´ë·®»ý»ê¿¡ ¸Å¿ì ÀûÇÕÇÏ´Ù. º» »ç¿¡¼­´Â ´Ù¾çÇÑ ±âÁõÀڷκÎÅÍ À¯·¡ÇÑ iPS ¼¼Æ÷ÁÖ¸¦ Á¦°øÇϰí ÀÖ´Ù. (ÇÏ´Ü Ç¥ Âü°í)

Characteristics of Cellartis human iPS cells

Code

Name

Age of donor (years)

Confirmed differentiation

Commercially
available differentiated cells

Karyotype (from
banked cells)

HLA typification

Y00275

Cellartis Human
iPS Cell Line 7
(ChiPSC7)

20

  • Hepatocytes
  • Beta cells
  • Cardiomyocytes
  • Endothelial cells
  • N/A

46, XX

  • HLA-A*03:01
  • HLA-B*07:02, HLA-B*35:01
  • HLA-C*04:01, HLA-C*07:02
  • HLA-DRB1*01:01, HLA-DRB1*15:01
  • HLA-DQB1*05:01, HLA-DQB1*06:02
  • HLA-DPB1*04:01, HLA-DPB1*04:02

Y00285

Cellartis Human iPS Cell Line 12 (ChiPSC12)

24

  • Hepatocytes
  • Beta cells
  • Cardiomyocytes
  • Neural progenitors
  • Endothelial cells
  • Cellartis Enhanced hiPS-HEP v2 (from ChiPSC12) Kit
  • Cellartis hiPS Beta Cells (from ChiPSC12) Kit

46, XY

  • HLA-A*01:01
  • HLA-B*08:01, HLA-B*37:01
  • HLA-C*06:02, HLA-C*07:01
  • HLA-DRB1*03:01, HLA-DRB1*11:04
  • HLA-DQB1*02:01, HLA-DQB1*03:01
  • HLA-DPB1*01:01, HLA-DPB1*04:01

Y00305

Cellartis Human
iPS Cell Line 18 (ChiPSC18)

32

  • Hepatocytes
  • Cardiomyocytes
  • Neural progenitors
  • Intestinal epithelial cells
  • Cellartis Enhanced hiPS-HEP v2 (from ChiPSC18) Kit
  • Cellartis Definitive Endoderm Cells (from ChiPSC18)
  • Cellartis Intestinal Epithelial Cells Y00325(from ChiPSC18) Kit

46, XY

  • HLA-A*23:01
  • HLA-B*07:02, HLA-B*49:01
  • HLA-C*07:01, HLA-C*07:02
  • HLA-DRB1*04:06, HLA-DRB1*07:01
  • HLA-DQB1*02:02, HLA-DQB1*04:02
  • HLA-DPB1*03:01, HLA-DPB1*04:01

Y00325

Cellartis Human
iPS Cell Line 22 (ChiPSC22)

32

  • Hepatocytes
  • Beta cells
  • Cardiomyocytes
  • Neural progenitors
  • Endothelial cells
  • Cellartis Enhanced hiPS-HEP v2 (from ChiPSC22) Kit
  • Cellartis hiPS Beta Cells (from ChiPSC22) Kit
  • Cellartis Cardiomyocytes (from ChiPSC22) Kit

46, XY

  • HLA-A*02:01
  • HLA-B*07:02, HLA-B*40:01
  • HLA-C*03:04, HLA-C*07:02
  • HLA-DRB1*13:02, HLA-DRB1*14:01
  • HLA-DQB1*05:03, HLA-DQB1*06:04
  • HLA-DPB1*03:01, HLA-DPB1*04:01

Ç¥ 1. Cellartis Human iPS Cells Á¤º¸
Characteristics of Cellartis human iPS cells. The cell lines were generated from fibroblasts using defective polycistronic retrovirus technology to deliver Oct-4, Sox-2, KLF-4, and c-Myc. The skin fibroblasts were obtained from donors of varying age and gender, have a normal karyotype, and have been confirmed to differentiate into specific cell lineages. Consent was obtained from all donors for commercial use.
±¸¼ºÇ°
  • Cellartis Human iPS Cell Lines (º°µµ±¸¸Å ºÒ°¡)
    ChiPSC7, ChiPSC12, ChiPSC18, ChiPSC22
  • Cellartis DEF-CS 100 Culture System (º°µµ±¸¸Å ºÒ°¡)
    DEF-CS Basal Medium 100 ml  
    DEF-CS COAT-1 800 ¥ìl - Plate coating
    DEF-CS GF-1
    DEF-CS GF-2
    DEF-CS GF-3
    300 ¥ìl
    100 ¥ìl
    40 ¥ìl
    Supplements
    Cellartis DEF-CS 500 Culture System (500 ml)Àº º°µµ ±¸¸Å°¡ °¡´ÉÇÕ´Ï´Ù.
Cell Line Ãë±Þ ÁÖÀÇ»çÇ× (Ŭ¸¯)

Keyword : iPScellline,stemcellline,Áٱ⼼Æ÷

hiPSC/hESC
>
Human iPS cellÀÇ È¿À²ÀûÀÎ ¹è¾çÀ» À§ÇÑ,
DEF-CS¢â Overview: ÇÑ ´«¿¡ º¸´Â Á¦Ç° Ư¡
>
Human iPSCÀÇ Monolayer ¹è¾ç°ú À¯ÀüÀÚ ÆíÁý¿¡ ..
DEF-CS 500 Culture System
>
Xeno-freeÀÇ Human iPS ¼¼Æ÷ / ES ¼¼Æ÷ ¹è¾ç½Ã..
Xeno-free & GMP DEF-CS culture medium